Prudential Financial
VYGR icon

Prudential Financial’s Voyager Therapeutics VYGR Stock Holding History

Prudential Financial’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-330,300
Closed -$1.87M – 2388
2024
Q4 		$1.87M Sell
330,300
-82,100
-20% -$529K ﹤0.01% 1323
2024
Q3 		$2.41M Buy
412,400
+297,100
+258% +$2.16M ﹤0.01% 1388
2024
Q2 		$912K Buy
+115,300
New +$967K ﹤0.01% 1887
2019
Q3 		– Sell
-62,670
Closed -$1.71M – 2477
2019
Q2 		$1.71M Sell
62,670
-3,630
-5% -$83.1K ﹤0.01% 1669
2019
Q1 		$1.27M Buy
66,300
+300
+0.5% +$3.91K ﹤0.01% 1791
2018
Q4 		$620K Sell
66,000
-790
-1% -$10.1K ﹤0.01% 1951
2018
Q3 		$1.26M Sell
66,790
-23,220
-26% -$446K ﹤0.01% 1794
2018
Q2 		$1.76M Buy
+90,010
New +$1.78M ﹤0.01% 1704

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's VYGR Position: Q1 2025 in Review

Prudential Financial sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 330,300 shares — an estimated $1.87M sold.

Prudential Financial first reported a position in VYGR in Q2 2018 and held it in 8 quarters. The position peaked at $2.41M in Q3 2024. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Prudential Financial reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Prudential Financial sold 330,300 Voyager Therapeutics shares in Q1 2025, an estimated $1.87M.
  • Prudential Financial first reported a position in Voyager Therapeutics in Q2 2018 and held it in 8 quarters.
  • Prudential Financial's Voyager Therapeutics position peaked at $2.41M in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Prudential Financial's 13F filing for Q1 2025, filed 13 May 2025.